Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020.

Rodrigues M, Koning L, Coupland SE, Jochemsen AG, Marais R, Stern MH, Valente A, Barnhill R, Cassoux N, Evans A, Galloway I, Jager MJ, Kapiteijn E, Romanowska-Dixon B, Ryll B, Roman-Roman S, Piperno-Neumann S; UM Cure 2020 Consortium.

Cancers (Basel). 2019 Jul 22;11(7). pii: E1032. doi: 10.3390/cancers11071032.

2.

No other interest can take precedence - a patient's perspective on oncology drug development.

Ryll B.

Nat Rev Clin Oncol. 2019 Aug;16(8):461-462. doi: 10.1038/s41571-019-0230-4. No abstract available.

PMID:
31110270
3.

Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference.

Smith JR, Pe'er J, Belfort RN, Cardoso F, Carvajal RD, Carvalho C, Coupland SE, Desjardins L, Francis JH, Gallie BL, Gombos DS, Grossniklaus HE, Heegaard S, Jager MJ, Kaliki S, Ksander BR, Maeurer M, Moreno E, Pulido JS, Ryll B, Singh AD, Zhao J, Parreira A, Wilson DJ, O'Brien JM.

Transl Vis Sci Technol. 2018 Jan 9;8(1):9. doi: 10.1167/tvst.8.1.9. eCollection 2019 Jan.

4.

Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study.

Makady A, Kalf RRJ, Ryll B, Spurrier G, de Boer A, Hillege H, Klungel OH, Goettsch W; GetReal Workpackage 1.

Health Qual Life Outcomes. 2018 Nov 29;16(1):222. doi: 10.1186/s12955-018-1047-z.

5.

Improving Patient Involvement in Medicines Research and Development:: A Practical Roadmap.

Geissler J, Ryll B, di Priolo SL, Uhlenhopp M.

Ther Innov Regul Sci. 2017 Sep;51(5):612-619. doi: 10.1177/2168479017706405. Epub 2017 May 8.

PMID:
30231692
6.

Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.

Makady A, Stegenga H, Ciaglia A, Debray TP, Lees M, Happich M, Ryll B, Abrams K, Thwaites R, Garner S, Jonsson P, Goettsch W.

J Comp Eff Res. 2017 Sep;6(6):485-490. doi: 10.2217/cer-2017-0044. Epub 2017 Aug 31.

7.

Personalized medicine in Europe: not yet personal enough?

Di Paolo A, Sarkozy F, Ryll B, Siebert U.

BMC Health Serv Res. 2017 Apr 19;17(1):289. doi: 10.1186/s12913-017-2205-4. Review.

8.

Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators.

Postmus D, Mavris M, Hillege HL, Salmonson T, Ryll B, Plate A, Moulon I, Eichler HG, Bere N, Pignatti F.

Clin Pharmacol Ther. 2016 May;99(5):548-54. doi: 10.1002/cpt.332. Epub 2016 Feb 17.

PMID:
26715217
9.

The genomic landscape underlying phenotypic integrity in the face of gene flow in crows.

Poelstra JW, Vijay N, Bossu CM, Lantz H, Ryll B, Müller I, Baglione V, Unneberg P, Wikelski M, Grabherr MG, Wolf JB.

Science. 2014 Jun 20;344(6190):1410-4. doi: 10.1126/science.1253226.

10.

The genome of Callorhinchus and the fossil record: a new perspective on SCPP gene evolution in gnathostomes.

Ryll B, Sanchez S, Haitina T, Tafforeau P, Ahlberg PE.

Evol Dev. 2014 May;16(3):123-4. doi: 10.1111/ede.12071. Epub 2014 Apr 8. No abstract available.

11.

3D microstructural architecture of muscle attachments in extant and fossil vertebrates revealed by synchrotron microtomography.

Sanchez S, Dupret V, Tafforeau P, Trinajstic KM, Ryll B, Gouttenoire PJ, Wretman L, Zylberberg L, Peyrin F, Ahlberg PE.

PLoS One. 2013;8(2):e56992. doi: 10.1371/journal.pone.0056992. Epub 2013 Feb 26.

Supplemental Content

Support Center